Literature DB >> 20056613

Defects in 18 S or 28 S rRNA processing activate the p53 pathway.

Michael Hölzel1, Mathias Orban, Julia Hochstatter, Michaela Rohrmoser, Thomas Harasim, Anastassia Malamoussi, Elisabeth Kremmer, Gernot Längst, Dirk Eick.   

Abstract

The p53 tumor suppressor pathway is activated by defective ribosome synthesis. Ribosomal proteins are released from the nucleolus and block human double minute-2 (Hdm2) that targets p53 for degradation. However, it remained elusive how abrogation of individual rRNA processing pathways contributes to p53 stabilization. Here, we show that selective inhibition of 18 S rRNA processing provokes accumulation of p53 as efficiently as abrogated 28 S rRNA maturation. We describe hUTP18 as a novel mammalian rRNA processing factor that is specifically involved in 18 S rRNA production. hUTP18 was essential for the cleavage of the 5'-external transcribed spacer leader sequence from the primary polymerase I transcript, but was dispensable for rRNA transcription. Because maturation of the 28 S rRNA was unaffected in hUTP18-depleted cells, our results suggest that the integrity of both the 18 S and 28 S rRNA synthesis pathways can be monitored independently by the p53 pathway. Interestingly, accumulation of p53 after hUTP18 knock down required the ribosomal protein L11. Therefore, cells survey the maturation of the small and large ribosomal subunits by separate molecular routes, which may merge in an L11-dependent signaling pathway for p53 stabilization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056613      PMCID: PMC2825431          DOI: 10.1074/jbc.M109.054734

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.

Authors:  D G Pestov; Z Strezoska; L F Lau
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  Regulation of HDM2 activity by the ribosomal protein L11.

Authors:  Marion A E Lohrum; Robert L Ludwig; Michael H G Kubbutat; Mary Hanlon; Karen H Vousden
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

3.  Insights into the evolution of the nucleolus by an analysis of its protein domain repertoire.

Authors:  Eike Staub; Petko Fiziev; André Rosenthal; Bernd Hinzmann
Journal:  Bioessays       Date:  2004-05       Impact factor: 4.345

Review 4.  The WD repeat: a common architecture for diverse functions.

Authors:  T F Smith; C Gaitatzes; K Saxena; E J Neer
Journal:  Trends Biochem Sci       Date:  1999-05       Impact factor: 13.807

5.  RNA polymerase I transcription and pre-rRNA processing are linked by specific SSU processome components.

Authors:  Jennifer E G Gallagher; David A Dunbar; Sander Granneman; Brianna M Mitchell; Yvonne Osheim; Ann L Beyer; Susan J Baserga
Journal:  Genes Dev       Date:  2004-10-15       Impact factor: 11.361

6.  Inhibition of HDM2 and activation of p53 by ribosomal protein L23.

Authors:  Aiwen Jin; Koji Itahana; Kevin O'Keefe; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.

Authors:  Carlos P Rubbi; Jo Milner
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

8.  Ribosomal protein S7 is both a regulator and a substrate of MDM2.

Authors:  Yan Zhu; Masha V Poyurovsky; Yingchun Li; Lynn Biderman; Joachim Stahl; Xavier Jacq; Carol Prives
Journal:  Mol Cell       Date:  2009-08-14       Impact factor: 17.970

9.  Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.

Authors:  Mu-Shui Dai; Hua Lu
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

10.  Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.

Authors:  Yanping Zhang; Gabrielle White Wolf; Krishna Bhat; Aiwen Jin; Theresa Allio; William A Burkhart; Yue Xiong
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

View more
  41 in total

1.  Characterization of an HIV-targeted transcriptional gene-silencing RNA in primary cells.

Authors:  Anne-Marie W Turner; Amanda M Ackley; Michael A Matrone; Kevin V Morris
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Las1L is a nucleolar protein required for cell proliferation and ribosome biogenesis.

Authors:  Christopher D Castle; Erica K Cassimere; Jinho Lee; Catherine Denicourt
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

3.  Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?

Authors:  Olivier Bensaude
Journal:  Transcription       Date:  2011-05

4.  Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Authors:  Xiang Zhou; Jun-Ming Liao; Wen-Juan Liao; Hua Lu
Journal:  Genes Cancer       Date:  2012-03

Review 5.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

6.  ATM-dependent E2F1 accumulation in the nucleolus is an indicator of ribosomal stress in early response to DNA damage.

Authors:  Ya-Qiong Jin; Guo-Shun An; Ju-Hua Ni; Shu-Yan Li; Hong-Ti Jia
Journal:  Cell Cycle       Date:  2014-03-25       Impact factor: 4.534

7.  Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.

Authors:  X Zhou; Q Hao; J Liao; Q Zhang; H Lu
Journal:  Oncogene       Date:  2012-03-05       Impact factor: 9.867

8.  1A6/DRIM, a novel t-UTP, activates RNA polymerase I transcription and promotes cell proliferation.

Authors:  Qunhui Peng; Jianguo Wu; Ying Zhang; Yun Liu; Ruirui Kong; Lelin Hu; Xiaojuan Du; Yang Ke
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

Review 9.  The nucleolus under stress.

Authors:  Séverine Boulon; Belinda J Westman; Saskia Hutten; François-Michel Boisvert; Angus I Lamond
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

Review 10.  Nucleolar control of p53: a cellular Achilles' heel and a target for cancer therapy.

Authors:  Nikolina Vlatković; Mark T Boyd; Carlos P Rubbi
Journal:  Cell Mol Life Sci       Date:  2013-05-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.